Fluphenazine and its toxic maculopathy

Ophthalmic Research

Volumn 36, Issue 4, 2004, Pages 237-239

  Lee, M S ^a   Fern, A I ^a  

^a HAIRMYRES HOSPITAL   (United Kingdom)

Author keywords

Fluphenazine; Maculopathy; Psychiatry

Indexed keywords

FLUPHENAZINE;

ADULT; ANAMNESIS; ARTICLE; CASE REPORT; CLINICAL FEATURE; ELECTROPHYSIOLOGY; ELECTRORETINOGRAPHY; FEMALE; FLUORESCENCE ANGIOGRAPHY; HUMAN; PRIORITY JOURNAL; RETINA INJURY; RETINA MACULOPATHY; VISUAL ACUITY;

ANTIPSYCHOTIC AGENTS; FEMALE; FLUORESCEIN ANGIOGRAPHY; FLUPHENAZINE; HUMANS; MIDDLE AGED; RETINA; RETINAL DISEASES;

EID: 4043152147     PISSN: 00303747     EISSN: None     Source Type: Journal    
DOI: 10.1159/000078784     Document Type: Article

References (6)

1. British National Formulary, ed 44. Sept 2002; 4.2.1:178.
2. Davidof FH: Thioridazine pigmentary retinopathy. Arch Ophthalmol 1973;90:251-255.
3. Fornaro P, Calabria G, Corallo G, Picotti GB: Pathogenesis of degenerative retinopathies induced by thioridazine and other antipsychotics: A dopamine hypothesis. Doc Ophthalmol 2002;105:41-49.
4. Power WJ, Travers SP, Mooney DJ: Welding arc maculopathy and fluphenazine. Br J Ophthahmol 1991;75:433-435.
5. Holopigian K, Clewner L, Seiple W, Kupersmith MJ: The effect of dopamine blockage on the human flash electroretinogram. Doc Ophthalmol 1994;86:1-10.
6. Neves MS, Jordon K, Dragt H: Extensive chorioretinopathy associated with very low dose thioridazine. Eye 1990;4:767-770.